Welcome to the Centre for Bioengineering and Biotechnology at the University of Waterloo
The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 130 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
A Message from the Centre's Director
At the Centre for Bioengineering and Biotechnology, we have over 130 researchers working in areas as diverse as new pharmaceutical delivery systems, lab testing on technologies as small as a computer chip, better and lower cost imaging systems, and software solutions for healthcare. Our researchers span all departments of the faculties of engineering and science, and includes researchers from other faculties as well. The common thread between researchers is a dedication to understanding how technology can work in conjunction with biology and people to make a better world.
The Centre for Bioengineering and Biotechnology is focused on partnerships. Success in this area requires strong partnerships between researchers, students, industry, healthcare and government. For this reason, the Centre welcomes members from these communities and encourages them to join the Centre and participate in our research. We host industry focus days, seminars, workshops, student events, and help build the right teams to tackle the toughest problems. Come join us, and work towards a better, healthier world through technology.
- Catherine Burns, Director, Centre for Bioengineering and Biotechnology
- Nov. 12, 2018
A digital X-ray imager developed by a Waterloo Engineering startup will be tested on patients with lung nodules in a pilot study at Grand River Hospital in Kitchener.
The new technology is faster and cheaper than traditional CT scans, and has the potential to detect lung cancer earlier and with less radiation exposure.
- Nov. 7, 2018
Engineering researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.
The new technology, called Pattern to Knowledge (P2K), can predict the binding of biosequences in seconds and potentially reduce bottlenecks in drug research.
P2K uses artificial intelligence (AI) to leverage deep knowledge from data instead of relying solely on classical machine learning.
- Oct. 22, 2018
There are over half a million Canadians living with dementia. Treatment of this devastating disorder is challenging as there are no drugs available to cure it. Developing a new drug, running clinical trials, and acquiring approval from regulatory agencies is expensive and time-consuming: the process can take decades and cost upwards of 4 billion dollars.
- Nov. 14, 2018
- Nov. 17, 2018
The Biotechnology and Bioengineering Conference (BioTEC 2018) will be held on Saturday, November 17 at the University of Waterloo.
- Nov. 21, 2018